S&P 500   3,841.47
DOW   30,996.98
QQQ   325.42
S&P 500   3,841.47
DOW   30,996.98
QQQ   325.42
S&P 500   3,841.47
DOW   30,996.98
QQQ   325.42
S&P 500   3,841.47
DOW   30,996.98
QQQ   325.42
Log in

Aspen Pharmacare Stock Forecast, Price & News

-0.36 (-3.63 %)
(As of 01/22/2021 12:00 AM ET)
Today's Range
Now: $9.56
50-Day Range
MA: $8.78
52-Week Range
Now: $9.56
Volume11,716 shs
Average Volume4,892 shs
Market Capitalization$4.36 billion
P/E Ratio11.66
Dividend YieldN/A
Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and supplies specialty, branded, and generic pharmaceutical products worldwide. It operates in Commercial Pharmaceuticals and Manufacturing segments. The company provides general anaesthetics and muscle relaxants under the Anaesthetics brand; cytotoxic medicines under the Regional brand; and injectable anticoagulants with a focus on low molecular weight heparins, Xa inhibitors, and heparin derivatives under the Thrombosis brand. It is also involved in the contract and supply of chemical and biochemical active pharmaceutical ingredients and finished dose form pharmaceuticals for third parties. The company offers products in the form of oral solid dose, injectables, liquids, semi-solids, steriles, biologicals, and active pharmaceutical ingredients. Aspen Pharmacare Holdings Limited was founded in 1850 and is headquartered in Durban, South Africa.
Aspen Pharmacare logo


Overall MarketRank

0.94 out of 5 stars

Medical Sector

1019th out of 1,923 stocks

Private Households Industry

148th out of 377 stocks

Analyst Opinion: 0.0Community Rank: 2.2Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 2.5 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Industry Private households
Previous SymbolNASDAQ:APNHY



Sales & Book Value

Annual Sales$2.49 billion
Cash Flow$1.16 per share
Book Value$9.77 per share



Market Cap$4.36 billion
Next Earnings DateN/A
OptionableNot Optionable
-0.36 (-3.63 %)
(As of 01/22/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive APNHY News and Ratings via Email

Sign-up to receive the latest news and ratings for APNHY and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Aspen Pharmacare (OTCMKTS:APNHY) Frequently Asked Questions

How has Aspen Pharmacare's stock price been impacted by Coronavirus (COVID-19)?

Aspen Pharmacare's stock was trading at $6.75 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, APNHY stock has increased by 41.6% and is now trading at $9.56.
View which stocks have been most impacted by COVID-19

What stocks does MarketBeat like better than Aspen Pharmacare?

Wall Street analysts have given Aspen Pharmacare a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Aspen Pharmacare wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Aspen Pharmacare?

Aspen Pharmacare saw a decrease in short interest in December. As of December 31st, there was short interest totaling 100 shares, a decrease of 75.0% from the December 15th total of 400 shares. Based on an average daily volume of 18,200 shares, the short-interest ratio is currently 0.0 days.
View Aspen Pharmacare's Short Interest

Who are some of Aspen Pharmacare's key competitors?

Who are Aspen Pharmacare's key executives?

Aspen Pharmacare's management team includes the following people:
  • Mr. Stephen Bradley Saad, Group CEO & Exec. Director (Age 56)
  • Mr. Michael Guy Attridge, Deputy Group Chief Exec., Fin. Director & Exec. Director (Age 59)
  • Mr. Sean M. Capazorio, Group Fin. Officer (Age 53)
  • Ms. Lorraine Hill, Group Operating Officer & Responsible Pharmacist (Age 56)
  • Mr. Riaan Verster BProc, LLM, LLB, ACIS, Company Sec., Group Governance Officer & Group Compliance Officer (Age 44)
  • Mr. Stavros Nicolaou, Group Sr. Exec. of Strategic Trade (Age 55)
  • Mr. Carnie van der Linde, Group Commercial Head (Age 51)
  • Mr. Trevor Julian Ziman, Chief Exec. Officer of Asia Pacific (Age 48)
  • Mr. Samer Kassem, Chief Exec. Officer of Aspen Global Incorporated (Age 45)
  • Ms. Luresha Chetty, Corp. Affairs & Investor Relations Exec.

What is Aspen Pharmacare's stock symbol?

Aspen Pharmacare trades on the OTCMKTS under the ticker symbol "APNHY."

How do I buy shares of Aspen Pharmacare?

Shares of APNHY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Aspen Pharmacare's stock price today?

One share of APNHY stock can currently be purchased for approximately $9.56.

How big of a company is Aspen Pharmacare?

Aspen Pharmacare has a market capitalization of $4.36 billion and generates $2.49 billion in revenue each year. The company earns $300.36 million in net income (profit) each year or $0.82 on an earnings per share basis. Aspen Pharmacare employs 10,000 workers across the globe.

What is Aspen Pharmacare's official website?

The official website for Aspen Pharmacare is www.aspenpharma.com.

How can I contact Aspen Pharmacare?

Aspen Pharmacare's mailing address is 9 Rydall Vale Park Douglas Saunders Drive La Lucia Ridge, Durban T3, 4051. The company can be reached via phone at 27-31-580-8600.

This page was last updated on 1/24/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.